Medtronic plc (MDT): Among Stocks to Buy from Dividend Stock Portfolio For Income

We recently published a list of Dividend Stock Portfolio For Income: Top 10 Stocks to Buy. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other stocks to buy from dividend stock portfolio for income.

There is a common misconception that dividend stocks are primarily suited for those nearing retirement. However, this is not the case. Both experienced and retail investors have long favored dividend stocks, as they provide a steady stream of income. Unlike growth companies, dividend-paying firms distribute a portion of their profits to shareholders. While dividend investing may seem simple, successfully implementing this strategy requires thorough research and careful analysis.

Financial advisor Michael Dinich discussed dividend investing in an interview with Business Insider. Here are some comments from the analyst:

“While low-cost index funds provide easily diversified exposure to the market with minimal effort, selecting individual dividend payers demands continued research to find suitable candidates.”

He further highlighted that dividend stocks serve as a reliable income source, which can either be reinvested to compound returns or used as cash for various financial needs. This makes them particularly valuable for younger investors, offering both market exposure and a consistent income stream. His insights align with the broader impact of dividend income on market returns over extended periods. According to a report by S&P Dow Jones Indices, from 1926 to July 2023, dividends contributed 32% of the monthly total return of the broader market, with the remainder driven by capital appreciation.

READ ALSO: Top 10 Dividend Stocks To Buy According To Hedge Funds

A study by WisdomTree emphasized the strong income potential of dividend-paying stocks. The report suggested that focusing on dividends can significantly boost investors’ dividend earnings and improve the trailing 12-month dividend yield. This approach is especially beneficial during periods of low yields and market uncertainty. Investing in dividend-weighted indexes may provide a reliable strategy for generating income in such challenging conditions.

For the past two years, dividend stocks have underperformed the broader market, largely due to increased investments in the AI sector. However, analysts remain optimistic about dividend growth, particularly as more technology companies introduce dividend policies to attract investors. According to a report by S&P Global, total US dividends are expected to rise by 7% in 2025, reaching $784 billion. In recent years, and continuing into the current fiscal year, key contributions to dividend growth have come from sectors such as energy, pharmaceuticals, financial services, banking, and REITs. The report also highlighted that the media and entertainment sector experienced a significant surge in total dividend payouts in 2024, climbing by 140%, largely driven by the dividend policies of two major companies. This upward trend is expected to continue in 2025, with the sector projected to see an 18.6% increase in dividend growth, leading the market once again.

While regular dividends are projected to increase, variable dividends are set to decline by approximately 50%, with estimates placing the total for 2025 at $13.5 billion. Across all US sectors, variable dividends are expected to shrink, as persistent inflation and higher interest rates have limited the additional cash flow available for distribution.

Our Methodology

For this list, we first used a stock screener to pick companies that have raised their dividends for at least 10 consecutive years or more. From that list, we narrowed down our options to companies with dividend yields of around 2%, as of February 25, demonstrating robust financial standings and consistent cash flow, which are indicative of their ability to sustain reliable dividends for passive income. From these companies we picked 10 stocks with the highest number of hedge fund investors, using Insider Monkey’s database of over 1,000 hedge funds and their holdings as of Q4 2024

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Medtronic plc (MDT): Among Stocks to Buy from Dividend Stock Portfolio For Income

A surgeon in a modern operating room holding advanced medical devices with a sense of purpose and accuracy.

Medtronic plc (NYSE:MDT)

Number of Hedge Fund Holders: 67

Medtronic plc (NYSE:MDT) ranks eighth on our list of the best stocks for a dividend stock portfolio. The multinational medical device company has a diversified business, offering a wide range of devices across four key sectors: medical-surgical, neuroscience, cardiovascular, and diabetes.

In fiscal Q3 2025, Medtronic plc (NYSE:MDT) posted revenue of $8.3 billion for the third quarter, reflecting a 2.5% increase from the same period last year. However, this figure fell slightly short of Wall Street’s consensus estimate of $8.33 billion. The company reported diluted earnings per share (EPS) of $1.01 under generally accepted accounting principles (GAAP). Meanwhile, adjusted EPS rose 7% year over year to $1.39, surpassing analysts’ expectations of $1.35.

Approximately 50% of Medtronic plc (NYSE:MDT)’s revenue is generated in the US, which remains the most profitable healthcare market globally. The remainder comes from international operations, including emerging markets that have the potential for faster growth in the years ahead. The company’s main revenue streams come from its cardiovascular, neuroscience, and surgical divisions, while its diabetes segment contributes a smaller portion. This diversified business model provides stability. Notably, when numerous medical procedures were postponed or canceled during the early years of the pandemic, it marked the first time since the mid-1980s that Medtronic’s trailing 12-month sales declined by 10%.

Medtronic plc (NYSE:MDT) showed a strong cash position in its earnings report. In the first nine months of its fiscal year, the company generated an operating cash flow of over $4.5 billion, and its free cash flow came in at $3.1 billion. Due to this strong cash position, the company was able to raise its dividend payouts for 47 years straight. The company offers a quarterly dividend of $0.70 per share and has a dividend yield of 3.09%, as of February 25.

Overall, MDT ranks 8th on our list of stocks to buy from dividend stock portfolio for income. While we acknowledge the potential for MDT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MDT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.